Sims JD, Taguiam JM, Alonso-Valenteen F, Markman J, Agadjanian H, Chu D, Lubow J, Abrol R, Srinivas D, Jain A, Han B, Qu Y, Mirzadehgan P, Hwang JY, Rentsendorj A, Chung A, Lester J, Karlan BY, Gray HB, Gross Z, Giuliano A, Cui X, Medina-Kauwe LK. Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics. J Control Release. 2018 Feb 10;271:127-138. https://www.sciencedirect.com/science/article/pii/S0168365917310945.
Han B, Zhou B, Qu Y, Gao B, Xu Y, Chung S, Tanaka H, Yang W, Giuliano AE, Cui X. FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer. Oncogene. 2018 Mar;37(10):1399-1408. https://www.nature.com/articles/s41388-017-0021-2.
Gao B, Qu Y, Han B, Nagaoka Y, Katsumata M, Deng N, Bose S, Jin L, Giuliano AE, Cui X. Inhibition of lobuloalveolar development by FOXC1 overexpression in the mouse mammary gland. Sci Rep. 2017 Oct 25;7(1):14017. https://www.nature.com/articles/s41598-017-14342-8.
Qu Y, Zhou B, Yang W, Han B, Yu-Rice Y, Gao B, Johnson J, Svendsen CN, Freeman MR, Giuliano AE, Sareen D, Cui X. Transcriptome and proteome characterization of surface ectoderm cells differentiated from human iPSCs. Sci Rep. 2016 Aug 23;6:32007. https://www.nature.com/articles/srep32007.
Yu-Rice Y, Jin Y, Han B, Qu Y, Johnson J, Watanabe T, Cheng L, Deng N, Tanaka H, Gao B, Liu Z, Sun Z, Bose S, Giuliano AE, Cui X. FOXC1 is involved in ERα silencing by counteracting GATA3 binding and is implicated in endocrine resistance. Oncogene. 2016 Oct 13;35(41):5400-5411. https://www.nature.com/articles/onc201678.
Han B, Qu Y, Jin Y, Yu Y, Deng N, Wawrowsky K, Zhang X, Li N, Bose S, Wang Q, Sakkiah S, Abrol R, Jensen TW, Berman BP, Tanaka H, Johnson J, Gao B, Hao J, Liu Z, Buttyan R, Ray PS, Hung MC, Giuliano AE, Cui X. FOXC1 activates smoothened-independent hedgehog signaling in basal-like breast cancer. Cell Rep. 2015 Nov 3;13(5):1046-1058. https://www.sciencedirect.com/science/article/pii/S2211124715011055.
Qu Y, Wang J, Ray PS, Guo H, Huang J, Shin-Sim M, Bukoye BA, Liu B, Lee AV, Lin X, Huang P, Martens JW, Giuliano AE, Zhang N, Cheng NH, Cui X. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-κB signaling. J Clin Invest. 2011;121(1):212-225. http://www.jci.org/articles/view/43144.
Ray PS, Wang J, Qu Y, Shin-Sim M, Shamonki J, Bagaria SP, Ye X, Liu B, Elashoff D, Hoon DSB, Giuliano AE, Cui X. FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer. Cancer Res. 2010;70(10):3870-3876. http://cancerres.aacrjournals.org/content/70/10/3870.
Liu S, Umezu-Goto M, Murph M, Lu Y, Liu W, Zhang F, Yu S, Stephens LC, Cui X, Murrow G, Coombes K, Muller W, Hung MC, Perou CM, Lee AV, Fang X, Mills GB. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases. Cancer Cell. 2009;15(6):539-550. http://www.cell.com/cancer-cell/abstract/S1535-6108(09)00115-9.
Contact the Cui Lab
8700 Beverly Blvd. Davis Building, Rooms 2055 and 2056 Los Angeles, CA 90048
This website converts English to other languages using an automated tool called Microsoft Translator™. The translations may include errors or change the intended meaning of the text. Please consult your healthcare provider about any medical information.
Translations may not be available for some items, including PDF documents, maps, video captions, and text that appears on photos. Also, some features on the website may not work in the translated versions.
This Web page converts English to other languages â â using an automated tool called Microsoft Translatorâ ¢. Translations may include errors or change the intended meaning of the text. Please consult your doctor about any medical information.
Translations may not be available for some articles, including PDF documents, maps, video legends and text that appears in the photos. Also, some of the features on the website may not work in the translated versions.